DOXO-EMCH: Clinical Trials

6 trials of DOXO-EMCH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 withdrawn. 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Withdrawn 2

Follow DOXO-EMCH: new trials by email Literature Review of DOXO-EMCH trials Research Report on DOXO-EMCH

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer
Nab-paclitaxel, Cisplatin, 5Fluorouracil - Non Small Cell Lung Cancer
Phase 2WithdrawnImmunityBio, Inc.2018-06-012025-02-21
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Aldoxorubicin, Topotecan - Metastatic Small Cell Lung Cancer
Phase 2CompletedImmunityBio, Inc.1352015-04-202024-06-25
Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
250 mg/m2 aldoxorubicin, 350 mg/m2 aldoxorubicin - Glioblastoma
Phase 2CompletedImmunityBio, Inc.282014-03-012024-05-29
Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer
INNO-206 - Pancreatic Ductal Adenocarcinoma
Phase 2CompletedImmunityBio, Inc.152012-05-162024-06-06
Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
INNO-206, Doxorubicin - Metastatic Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma
Phase 2CompletedImmunityBio, Inc.1262012-01-112024-05-29
INNO-206 in Patients With Small Cell Lung Cancer (SCLC)
INNO-206 - Small Cell Lung Cancer
Phase 2WithdrawnCytRx2008-05-012012-02-09

Conditions studied

Small Cell Lung Carcinoma (2)  ·  Brain Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Glioblastoma (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcoma (1)

Sponsors

ImmunityBio, Inc. (5)  ·  CytRx (1)

Countries

United States (6)  ·  Hungary (2)  ·  Australia (1)  ·  India (1)  ·  Romania (1)  ·  Russia (1)  ·  Spain (1)  ·  Ukraine (1)

Top investigators

Daniel Levitt, M.D., Ph.D. (1)  ·  Daniel Levitt, MD, PhD (1)  ·  Daniel Von Hoff, MD, FACP (1)  ·  Michael Maitland, MD (1)  ·  Sant Chawla, M.D. (1)

Results publications

PMID 26378637